Sotera Health Company
SHC
$17.15
$0.543.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.64% | -12.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.64% | -12.29% | |||
| Cost of Revenue | 7.25% | -5.36% | |||
| Gross Profit | 23.03% | -17.60% | |||
| SG&A Expenses | 8.26% | -1.95% | |||
| Depreciation & Amortization | -39.34% | -0.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.63% | -4.07% | |||
| Operating Income | 46.78% | -28.25% | |||
| Income Before Tax | 227.48% | -132.97% | |||
| Income Tax Expenses | 799.62% | -104.79% | |||
| Earnings from Continuing Operations | 160.05% | -207.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 160.05% | -207.60% | |||
| EBIT | 46.78% | -28.25% | |||
| EBITDA | 24.37% | -19.71% | |||
| EPS Basic | 159.83% | -207.59% | |||
| Normalized Basic EPS | 135.25% | -48.61% | |||
| EPS Diluted | 156.00% | -214.94% | |||
| Normalized Diluted EPS | 133.81% | -48.14% | |||
| Average Basic Shares Outstanding | 0.13% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.78% | -0.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||